Development of Novel Drugs for High Risk Triple Negative

Project: Research project

Project Details

Description

Development of Novel Drugs for High Risk Triple Negative Breast Cancer Treatment
StatusFinished
Effective start/end date3/15/158/31/19

Funding

  • US ARMY MED RESEARCH & MATERIEL COMMAND

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.